155 related articles for article (PubMed ID: 1989160)
1. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.
Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL
Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160
[No Abstract] [Full Text] [Related]
2. Cancer development in pediatric primary renal allograft recipients.
Gruber SA; Gillingham K; Sothern RB; Stephanian E; Chavers B; Matas AJ; Dunn DL
Transplant Proc; 1994 Feb; 26(1):3-4. PubMed ID: 8108991
[No Abstract] [Full Text] [Related]
3. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA.
Sheil AG; Disney AP; Mathew TH; Amiss N; Excell L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1111-2. PubMed ID: 1989161
[No Abstract] [Full Text] [Related]
4. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
[TBL] [Abstract][Full Text] [Related]
5. Cancers after cyclosporine therapy.
Penn I
Transplant Proc; 1988 Feb; 20(1 Suppl 1):276-9. PubMed ID: 3279617
[No Abstract] [Full Text] [Related]
6. Immunoblastic lymphoma in a cyclosporine-treated renal transplant recipient.
Bia MJ; Flye MW
Transplantation; 1985 Jun; 39(6):673-5. PubMed ID: 3890296
[No Abstract] [Full Text] [Related]
7. Cancer after transplantation in Catalonia.
Vilardell J; Oppenheimer F; Castelao AM; Puig JM; Cantarell MC; Solá R; Lauzurica R
Transplant Proc; 1992 Feb; 24(1):124. PubMed ID: 1539205
[No Abstract] [Full Text] [Related]
8. Occurrence of cancers in immunosuppressed organ transplant recipients.
Penn I
Clin Transpl; 1994; ():99-109. PubMed ID: 7547597
[TBL] [Abstract][Full Text] [Related]
9. De novo malignancy following liver transplantation: a single-center study.
Levy M; Backman L; Husberg B; Goldstein R; McMillan R; Gibbs J; Gonwa TA; Holman M; Klintmalm G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1397-9. PubMed ID: 8442153
[No Abstract] [Full Text] [Related]
10. Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
Batiuk TD; Barry JM; Bennett WM; Meyer MM; Tolzman D; Norman DJ
Transplant Proc; 1993 Feb; 25(1 Pt 2):1391. PubMed ID: 8382860
[No Abstract] [Full Text] [Related]
11. Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.
Hricik DE; Bartucci MR; Moir EJ; Mayes JT; Schulak JA
Transplant Proc; 1991 Feb; 23(1 Pt 2):1007-8. PubMed ID: 1989139
[No Abstract] [Full Text] [Related]
12. Posttransplant malignancies in pediatric organ transplant recipients.
Penn I
Transplant Proc; 1994 Oct; 26(5):2763-5. PubMed ID: 7940870
[No Abstract] [Full Text] [Related]
13. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
Boudreaux JP; McHugh L; Canafax DM; Asher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1811-3. PubMed ID: 3079040
[No Abstract] [Full Text] [Related]
14. Anemia associated with pregnancy in a cyclosporine-treated renal allograft recipient.
Zeidan BS; Waltzer WC; Monheit AG; Rapaport FT
Transplant Proc; 1991 Aug; 23(4):2301-3. PubMed ID: 1871876
[No Abstract] [Full Text] [Related]
15. The risk of neoplasms in patients treated with cyclosporine A.
Cockburn IT; Krupp P
J Autoimmun; 1989 Oct; 2(5):723-31. PubMed ID: 2679624
[TBL] [Abstract][Full Text] [Related]
16. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
17. Cancers after cyclosporine therapy.
Penn I; Brunson ME
Transplant Proc; 1988 Jun; 20(3 Suppl 3):885-92. PubMed ID: 3388524
[No Abstract] [Full Text] [Related]
18. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune.
Cockburn I
Transplant Proc; 1987 Feb; 19(1 Pt 2):1804-7. PubMed ID: 3547886
[No Abstract] [Full Text] [Related]
19. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
Buturović J; Kandus A; Malovrh M; Bren A; Drinovec J
Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
[No Abstract] [Full Text] [Related]
20. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
Hiesse C; Kriaa F; Rieu P; Larue JR; Benoit G; Bellamy J; Blanchet P; Charpentier B
Transplant Proc; 1995 Feb; 27(1):972-4. PubMed ID: 7879250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
